Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1922 1
1930 1
1931 1
1932 2
1935 1
1936 1
1938 1
1939 1
1941 1
1944 1
1946 1
1947 1
1948 1
1950 2
1956 1
1958 1
1966 1
1967 1
1970 1
1971 1
1972 3
1973 1
1974 1
1975 1
1976 3
1977 3
1978 4
1979 5
1980 6
1981 3
1982 8
1984 3
1985 6
1986 4
1987 7
1988 8
1989 7
1990 13
1991 17
1992 16
1993 21
1994 20
1995 15
1996 16
1997 19
1998 19
1999 19
2000 17
2001 24
2002 13
2003 19
2004 16
2005 21
2006 20
2007 23
2008 13
2009 10
2010 23
2011 25
2012 17
2013 14
2014 13
2015 9
2016 19
2017 29
2018 19
2019 12
2020 15
2021 25
2022 28
2023 23
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

661 results

Results by year

Filters applied: . Clear all
Page 1
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.
Lincoff AM, Brown-Frandsen K, Colhoun HM, Deanfield J, Emerson SS, Esbjerg S, Hardt-Lindberg S, Hovingh GK, Kahn SE, Kushner RF, Lingvay I, Oral TK, Michelsen MM, Plutzky J, Tornøe CW, Ryan DH; SELECT Trial Investigators. Lincoff AM, et al. Among authors: emerson ss. N Engl J Med. 2023 Dec 14;389(24):2221-2232. doi: 10.1056/NEJMoa2307563. Epub 2023 Nov 11. N Engl J Med. 2023. PMID: 37952131 Clinical Trial.
Semaglutide for cardiovascular event reduction in people with overweight or obesity: SELECT study baseline characteristics.
Lingvay I, Brown-Frandsen K, Colhoun HM, Deanfield J, Emerson SS, Esbjerg S, Hardt-Lindberg S, Hovingh GK, Kahn SE, Kushner RF, Lincoff AM, Marso SP, Fries TM, Plutzky J, Ryan DH; SELECT Study Group. Lingvay I, et al. Among authors: emerson ss. Obesity (Silver Spring). 2023 Jan;31(1):111-122. doi: 10.1002/oby.23621. Epub 2022 Dec 10. Obesity (Silver Spring). 2023. PMID: 36502289 Free PMC article. Clinical Trial.
Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design.
Ryan DH, Lingvay I, Colhoun HM, Deanfield J, Emerson SS, Kahn SE, Kushner RF, Marso S, Plutzky J, Brown-Frandsen K, Gronning MOL, Hovingh GK, Holst AG, Ravn H, Lincoff AM. Ryan DH, et al. Among authors: emerson ss. Am Heart J. 2020 Nov;229:61-69. doi: 10.1016/j.ahj.2020.07.008. Epub 2020 Jul 17. Am Heart J. 2020. PMID: 32916609 Free article.
Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.
Marso SP, McGuire DK, Zinman B, Poulter NR, Emerson SS, Pieber TR, Pratley RE, Haahr PM, Lange M, Brown-Frandsen K, Moses A, Skibsted S, Kvist K, Buse JB; DEVOTE Study Group. Marso SP, et al. Among authors: emerson ss. N Engl J Med. 2017 Aug 24;377(8):723-732. doi: 10.1056/NEJMoa1615692. Epub 2017 Jun 12. N Engl J Med. 2017. PMID: 28605603 Free PMC article. Clinical Trial.
Hepatitis E.
Emerson SU, Purcell RH. Emerson SU, et al. Pediatr Infect Dis J. 2007 Dec;26(12):1147-8. doi: 10.1097/INF.0b013e31815dd7c2. Pediatr Infect Dis J. 2007. PMID: 18043454 Review. No abstract available.
Hepatitis E virus.
Emerson SU, Purcell RH. Emerson SU, et al. Rev Med Virol. 2003 May-Jun;13(3):145-54. doi: 10.1002/rmv.384. Rev Med Virol. 2003. PMID: 12740830 Review.
Revisiting FDA Approval of Aducanumab.
Alexander GC, Knopman DS, Emerson SS, Ovbiagele B, Kryscio RJ, Perlmutter JS, Kesselheim AS. Alexander GC, et al. Among authors: emerson ss. N Engl J Med. 2021 Aug 26;385(9):769-771. doi: 10.1056/NEJMp2110468. Epub 2021 Jul 28. N Engl J Med. 2021. PMID: 34320282 No abstract available.
661 results